2型糖尿病患者的移动健康干预:一项随机临床试验
Ben S Gerber1,2, Alana Biggers2, Jessica J Tilton3
1Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester.
JAMA network open
|September 29, 2023
概括
临床药剂师和健康教练使用的移动健康工具显著改善了2型糖尿病非洲裔美国人和拉丁裔成年人的血红蛋白A1c (HbA1c) 水平,从而有可能减少健康差异.
科学领域:
- 数字健康数字健康
- 糖尿病管理 糖尿病管理
- 健康差异 在健康上的差异
背景情况:
- 2型糖尿病不成比例地影响着非洲裔美国人和拉丁裔人口.
- 移动健康 (mHealth) 干预措施在治疗慢性疾病方面表现有前途.
- 现有的干预措施可能无法充分满足不同患者群体的需求.
研究的目的:
- 评估由临床药剂师和健康教练提供的移动健康 (mHealth) 干预措施在改善2型糖尿病非洲裔美国人和拉丁裔成年人的血糖控制 (HbA1c) 的有效性.
- 评估mHealth工具对二次结果的影响,包括血压,胆固醇和生活质量.
主要方法:
- 一项随机临床试验,涉及221名非洲裔美国人或拉丁裔患者,患有2型糖尿病和HbA1c升高 (≥8%).
- 参与者接受了为期一年的移动健康干预 (远程医疗,短信,面对面指导),然后接受通常的护理,或者接受通常的护理,然后接受移动健康干预.
- 结果,包括HbA1c,在24个月的时间内每6个月测量一次.
主要成果:
- 在第一年,mHealth干预组的平均HbA1c降低为-0.79个百分点,而对照组的平均降低为-0.24个百分点 (P=.005).
- 等候名单对照组在第二年接受干预后实现了类似的HbA1c降低 (-0.57个百分点).
- 在两组之间的二次结果中没有发现显著差异.
结论:
- 临床药剂师和健康教练提供的移动健康干预可以有效地改善2型糖尿病的非洲裔美国人和拉丁裔成年人的HbA1c水平.
- 这种方法有可能减少糖尿病护理中的种族和民族差异.
- 持续的好处和对二次结果的影响需要进一步调查.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Management and Pharmacotherapy
302
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
223
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
223
Diabetes: Symptoms, Diagnosis, and Complications
573
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
573


